Tower Research Capital LLC (Trc) Cel Sci Corp Transaction History

Tower Research Capital LLC (Trc)

$3.29 Billion
Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Cel Sci Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 19,211 shares of CVM stock, worth $4,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,211

Previous 11,048 73.89%

Holding current value

$4,226

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.23 - $0.45 $1,877 - $3,673	8,163 Added 73.89%	19,211 $4,000
Q4 2024 Feb 13, 2025	BUY	$0.4 - $1.11 $4,059 - $11,264	10,148 Added 1127.56%	11,048 $4,000
Q3 2024 Nov 14, 2024	BUY	$1.05 - $1.5 $139 - $199	133 Added 17.34%	900 $0
Q2 2024 Aug 13, 2024	SELL	$1.11 - $1.85 $5,175 - $8,626	-4,663 Reduced 85.87%	767 $0
Q1 2024 May 15, 2024	SELL	$1.63 - $3.08 $17,551 - $33,165	-10,768 Reduced 66.48%	5,430 $10,000
Q4 2023 Feb 13, 2024	BUY	$1.07 - $3.07 $16,511 - $47,373	15,431 Added 2011.86%	16,198 $44,000
Q4 2022 Feb 10, 2023	SELL	$1.99 - $3.52 $111 - $197	-56 Reduced 6.8%	767 $2,000
Q3 2022 Nov 10, 2022	BUY	$3.09 - $5.23 $173 - $292	56 Added 7.3%	823 $2,000
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $14,706 - $28,443	-5,700 Reduced 88.14%	767 $3,000
Q1 2022 May 12, 2022	SELL	$3.93 - $7.7 $20,219 - $39,616	-5,145 Reduced 44.31%	6,467 $26,000
Q4 2021 Feb 14, 2022	BUY	$7.1 - $12.82 $5,367 - $9,691	756 Added 6.96%	11,612 $83,000
Q3 2021 Nov 15, 2021	BUY	$7.64 - $12.49 $17,235 - $28,177	2,256 Added 26.23%	10,856 $119,000
Q2 2021 Aug 16, 2021	BUY	$8.68 - $27.49 $60,352 - $191,137	6,953 Added 422.16%	8,600 $75,000
Q1 2021 May 17, 2021	SELL	$12.0 - $27.64 $7,956 - $18,325	-663 Reduced 28.7%	1,647 $25,000
Q4 2020 Feb 16, 2021	SELL	$11.05 - $16.62 $490,774 - $738,160	-44,414 Reduced 95.06%	2,310 $27,000
Q3 2020 Nov 16, 2020	BUY	$11.69 - $14.54 $237,482 - $295,380	20,315 Added 76.92%	46,724 $596,000
Q2 2020 Aug 13, 2020	BUY	$9.75 - $17.6 $257,487 - $464,798	26,409 New	26,409 $394,000
Q4 2019 Feb 07, 2020	SELL	$6.71 - $9.55 $9,756 - $13,885	-1,454 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$6.0 - $9.6 $2,790 - $4,464	465 Added 47.02%	1,454 $13,000
Q2 2019 Aug 13, 2019	BUY	$3.77 - $8.67 $3,728 - $8,574	989 New	989 $8,000

Others Institutions Holding CVM

# of Institutions

Shares Held

7.56M

Call Options Held

73.8K

Put Options Held

106K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $9.54M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Cel Sci Corp Transaction History